Equity
€768,563 ▲ 112%
Equity rose in 2025 from €361,902 to €768,563.
FHP
Lifetime
4 annual accounts with figures on one time axispeak -€91,475 (2025)
-€91,475▲ €304,229
lowest -€1.6m (2022)
-€93,339▲ €302,916
peak €1.5m (2022)
€768,563▲ 112%
€4,659▼ 82.3%
Board6 names since 2021
6 directors and 5 others
Owners
20%
Documentsfilings and deeds
23-09-202654 days late
2025micro format
Gross margin from -€395,705 to -€91,475Loss of €93,339Equity from €361,902 to €768,563Debts from €26,257 to €4,659Cash from €374,488 to €769,534
Key points
from the 2025 annual accountsLosses
-€2.8m in four years
Every financial year from 2022 to 2025 closed with a loss. 2022 was the heaviest.
Filings
4 annual accounts 2 late
The 2025 accounts came latest: 54 days after the end of the period.
Starting capital
€3,000 3,000 shares
Board
1 joined · 1 left
Board changed. Latest change 10-02-2026 · 5 in office.
Position in the sector
-€93,339
Lower net result than 95% of companies in human health. Sector median €59,563 · 21,317 companies.
Turnover not published (micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 224 companies had the same profile as FHP has now. Each dot is one company, two years later.
88.4%
were still trading
7.1%
stopped another way
4.0%
went bankrupt
Another 0.4% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 224 companies, not a prediction for FHP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, , since 28-01-2021
Director, since 28-01-2021
Director, since 28-01-2021
Director, since 28-01-2021
Director, , since 30-01-2026
- 20%equity €87.2m (2025) · 2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0762693578
Capital decrease of €2,500,000
Resignation: (director) · Appointment: (director) · Permanent representative: · General meeting of 30-01-2026 · Gazette deed
Capital increase of €6,100,000 to €6,103,000
Capital from €3,000 to €6,103,000, 1,200 new shares · Contributions: (€1,830,000, 360 shares); (€4,270,000, 840 shares) · Appointments: (director), (director), (director) and (class B director) · General meeting of 05-02-2021 · Gazette deed
Incorporation
Founding capital of €3,000, 3,000 shares · Founders: , and · Appointments: , and · published on 02-02-2021 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| FHP Bornem | - | - | 99.4% | - |
| DName-iT Leuven | - | - | 21.5% | - |
| SPOTWATCH Antwerpen Aalter | - | - | -28.1% | 0.9 |
| Klinisch Biologen ZAS Antwerp | - | - | 1.7% | - |
| ABBIO Watermael-Boitsfort | €569,744 | -17.1% | -22.6% | - |
| ECG Labs Lummen | €686,126 | -35.8% | 36.2% | 1 |
| Expert Service & Advice in Healthcare Hoeilaart | - | - | 98.2% | - |
These companies have the same main activity as FHP: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €388,000 and €2.6m, founded between 2009 and 2024.
Official details
Source: KBO- Status
- Active since 29-01-2021Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Establishment unit
- 2.313.191.7612880 Bornem, since 29-01-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2026
Insights on FHP
FHP files the micro format. That format states no turnover. The gross margin rose from -€1.6m in 2022 to -€91,475 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about FHP
- What is the company number of FHP?
- The company number of FHP is 0762.693.578. The VAT number is the same number with BE in front: BE 0762.693.578.
- Where is FHP based?
- The registered office is at Scheldestraat 31, 2880 Bornem.Company details
- What does FHP do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of FHP?
- FHP is a private limited company (BV).
- When was FHP founded?
- FHP was founded on 29-01-2021.
- Is FHP still active?
- Yes, FHP is an active enterprise in the KBO register.
- What is the turnover of FHP?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is FHP profitable?
- In financial year 2025, FHP made a loss of €93,339.
- Where can I find the annual accounts of FHP?
- FHP filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FHP due?
- FHP must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.